DOI: https://doi.org/10.22141/2224-0551.8.59.2014.75879

Experience of Using Levocetirizine in Pediatric Practice

Yu.V. Marushko

Abstract


The paper represents the latest views on antihistamine drugs use in pediatrics. For today, the most essential issue at acute and chronic allergic diseases in children is the use of new antihistamine drug — levocetirizine.

Keywords


allergy; children; levocetirizine.

References


Аллергический ринит и его влияние на астму, 2008. В сотрудничестве с Всемирной организацией здравоохранения // Рос. аллерголог. журн. — 2010. — Т. 1. — С. 74-86.

Беш Л.В. Алергологія дитячого віку: проблеми і перспективи // Мат. наук.-практ. конф., присвяч. 5-й річниці Львівського міського дитячого алергологічного центру. — Львів, 2005. — С. 5-14.

Викторов А.П. Побочные действия современных противогистаминных лекарственных средств // Doctor. — 2006. — № 2. — С. 22-24.

Гришко П.В., Старунова Т.Г. Опыт применения левоцетиризина у больных аллергическими заболеваниями // Аллергология. — 2007. — № 18 (175). — С. 49-51.

Марушко Ю.В., Шеф Г.Г. Можливості застосування левоцетиризину в терапії бронхітів та пневмоній у дітей з атопічними станами // Здоровье ребенка. — 2013. — № 4 (47). — С. 39-43.

П’ятницький Ю.С. Харчова алергія в дітей // Здоров’я України. — 2006, жовтень. — С. 31-32.

Трусова О.В., Коростовцев Д.С. Левоцетиризин (Ксизал). Характеристика препарата и опыт клинического применения // Аллергология. — 2006. — № 2. — С. 25-31.

Федоскова Т.Г., Ильина Н.И. Роль аллергических заболеваний в общеклинической практике // РМЖ (Клинические рекомендации и алгоритмы для практикующих врачей, социально-значимые заболевания). — 2004. — Т. 12 (14). — С. 876-885.

Allotey P., Reidpath D.D., Elisha D. Social medication and the control of children: a qualitative study of over-the-counter medication among Australian children // Pediatrics. — 2004. — 114. — e 378-83.

Bousquet J., Demerteau N., Mullol J. et al. Cost associated with persistent allergic rhinitis are reduced by levocetirizine // Allergy. — 2005. — Vol. 60. — P. 788-794.

Buck L. Cetirizine and Levocetirizine Use in Children // Pediatr. Pharm. — 2010. — Vol. 16. — P. 225-234.

Chen C. Physicochemical, pharmacological and pharmacokinetic properties of the zwitterionic antihistamines cetirizine and levocetirizine // Curr. Med. Chem. — 2008. — Vol. 15 (21). — P. 2173-2191.

Cobb D.B., Watson W.A., Fernandez M.C. High-dose loratadine exposure in a six-year-old child // Vet. Hum. Toxicol. — 2001. — 43. — 163-164.

Cranswick N., Turzikova J., Fuchs M., Hulhoven R. Levocetirizine in 1–2 year old children: pharmacokinetic and pharmacodynamic profile // Int. J. Clin. Pharmacol. Ther. — 2005. — 43. — 172-7.

Devalia J.L. et al. A randomized, double-blind, crossover comparison among cetirizine, levocetirizine, and ucb 28557 on histamine-induced cutaneous responses in healthy adult volunteers // Allergy. — 2001. — Vol. 56. — P. 50-57.

Gandon J.M., Allain H. Lack of effect of single and repeated doses of levocetirizine, a new anthihistamine drug, on cognitive and psychomotor functions in healthy volunteers // J. Clin. Pharmacol. — 2002. — Vol. 54. — P. 51-58.

Gillard M., Christophe B., Wels B. et al. Н1 antagonists: receptor affinity versus selectivity // Inflamm. Res. — 2003. — Vol. 52. (Suppl. 1). — S. 49-50.

Grant A.J., Riethuisen J.-M., Moulaert B., De Vos C. A double-blind, randomized, single-dose, crossover comparison of levocetirizine with ebastine, fexofenadine, loratadine, mizolastine, and placebo: suppression of histamine-induced wheal-and-flare response during 24 hours in healthy male subjects // Ann. Allergy Asthma Immunol. — 2002. — Vol. 88. — P. 190-197.

Hugo P. Van Bever, Sudesh T. Samuel, Bee Wah Lee. Halting the Allergic March // WAO Journal. — 2008. — P. 57-62.

Kapp A., Pichler W.J. Levocetirizine is an effective treatment in patients suffering from chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled, parallel, multicenter study // Int. J. Dermatol. — 2006. — Vol. 45 (4). — P. 469-474.

Klimek L. Levocetirizine: from scientific evidence to a potent modern-day treatment of today’s allergic patients // Drugs Today (Barc.). — 2009. — Vol. 45 (3). — P. 213-225.

Larbig M., Stamm H., Hohlfeld J., Krug N. Levocetirizine but not desloratadine inhibits histamine-induced changes of nasal temperature measured by facial thermography // EAACI, 2003.

Levocetirizine. Drug Facts and Comparisons 4.0. Efacts [online]. 2010. Available from Wolters Kluwer Health, Inc. (accessed 4/19/10).

Potter P.C. Paediatric Levocetirizine Study Group Efficacy and safety of levocetirizine on symptoms and health-related quality of life of children with perennial allergic rhinitis: a double-blind, placebo-controlled randomized clinical trial. Annals of allergy, asthma & immunology: official publication of the American Collegeof Allergy // Asthma, Immunology. — 2005. — Vol. 95 (2). — P. 175-180.

Shih M.Y., Hsu J.Y., Weng Y.S., Fu L.S. Influence of cetirizine and levocetirizine on two cytokines secretion in human airway epithelial cells // Allergy Asthma Proc. — 2008. — Vol. 29 (5). — P. 480-485.

Schmidt B., Sreeram N., Brockmeier K. Verlangerung des QT-Intervalls im Oberflachen-Ekg // Padiatrische Praxis. — 2009. — Bd. 73. — S. 279-286.

Steinbrook R. Testing medications in children // N. Engl. J. Med. — 2002. — Vol. 347. — P. 1462-1470.

Simons F. Early Prevention of Asthma in Atopic Children Study Group. Safety of levocetirizine treatment in young atopic children: an 18-month study // Pediatr. Allergy and Immunolog. — 2007. — Vol. 18. — P. 535-542.

Simons F.E.R. H1-antihistamines in children // Simons F.E.R., ed. Histamine and H1-Antihistamines in Allergic Disease. — 2nd ed. — New York, N.Y.: Marcel Dekker, Inc., 2002. — 437-64.

Simons F.E.R., Simons K.J. Levocetirizine: pharmacokinetics and pharmacodynamics in children age 6 to11 years // J. Allergy Clin. Immunol. — 2005. — 116. — 355-61.

Simons F.E.R., Silas P., Portnoy J.M., Catuogno J., Chapman D., Olufade A.O. Safety of cetirizine in infants 6 to 11 months of age: a randomized, double-blind, placebo-controlled trial // J. Allergy Clin. Immunol. — 2003. — 111. — 1244-8.

Walter Canonica G., Bousquet J., Van Hammee G. et al. XPERT Study Group Levocetirizine improves health-related quality of life and health status in persistent allergic rhinitis // Respiratory medicine. — 2006. — Vol. 100 (10). — P. 1706-1715.

Warner J. A double-blinded, randomized, placebo-controlled trial of cetirizine in preventing the onset of asthma in children with ato­pic dermatitis: 18 months treatment and 18 months posttreatment follo­w-up // J. Allergy Clin. Immunol. — 2001. — Vol. 108. — P. 929-937.

Xyzal® (Levocetirizine) prescribing information. UCB, Inc., August 2009. Available at www.xyzal.com (accessed 5/15/10).




Copyright (c) 2016 CHILD`S HEALTH

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© Publishing House Zaslavsky, 1997-2018

 

   Seo анализ сайта